ArticleFrontiers in neurology2021

Safety and Tolerability, Dose-Escalating, Double-Blind Trial of Oral Mannitol in Parkinson's Disease.

Eduard Linetsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.